Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03565406
Brief Title: A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma

First Submitted : June 12, 2018
First Submitted that Met QC Criteria : June 12, 2018
First Posted : June 21, 2018

Last Update Submitted that Met QC Criteria : May 19, 2020
Last Update Posted : May 21, 2020